Anson Funds Management LP Sellas Life Sciences Group, Inc. Transaction History
Anson Funds Management LP
- $549 Million
- Q1 2025
A detailed history of Anson Funds Management LP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 7,579,095 shares of SLS stock, worth $11.8 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
7,579,095
Previous 1,192,266
535.69%
Holding current value
$11.8 Million
Previous $1.2 Million
579.82%
% of portfolio
1.49%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding SLS
# of Institutions
50Shares Held
14.4MCall Options Held
538KPut Options Held
26.3K-
Vanguard Group Inc Valley Forge, PA2.84MShares$4.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.28 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$671,3740.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il350KShares$545,2270.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $32.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...